HIV & AIDS

Immune cells engineered in lab to resist HIV infection

Researchers at the Stanford University School of Medicine have found a novel way to engineer key cells of the immune system so they remain resistant to infection with HIV, the virus that causes AIDS.

HIV & AIDS

Rutgers laboratory helped to create new HIV drug

Two decades after a Rutgers team began working with legendary drug developer Paul Janssen, founder of a Belgian subsidiary of pharmaceutical giant Johnson & Johnson in an effort to create new and potent drugs to fight AIDS, ...

HIV & AIDS

AIDS fight enters new phase with prevention pill

(AP) -- Condoms and other safe-sex practices have accomplished only so much. Now the 30-year battle against AIDS is on the verge of a radical new phase, with the government expected to endorse a once-a-day pill to prevent ...

HIV & AIDS

Neutralizing HIV function

(Medical Xpress) -- Northeastern researchers have played a key role in studying how antibodies that neutralize HIV function are structured, a further step in ongoing global efforts by scientists to develop a vaccine for the ...

HIV & AIDS

To cheers, HIV drugs trial sets AIDS campaign on new course

Researchers at a world AIDS conference Monday stood up to cheer a trial proving that early use of drugs to treat HIV all but eliminates the risk of transmitting the killer virus through heterosexual intercourse.

page 6 from 21